Risk-Based Approach “Critical” To Securing Global Supply Chain – FDA

FDA wants risk-based draft guidances it published this year to increase industry accountability and free resources for high-risk inspections as the number of foreign-sourced drugs entering the U.S. exceeds the agency's inspection capabilities